Literature DB >> 8261814

Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children.

P Marcellin1, J Bernuau, M Martinot-Peignoux, D Larzul, L Z Xu, S Tran, A Bezeaud, M C Guimont, M Levardon, P Aumont.   

Abstract

The prevalence of hepatitis C virus (HCV) infection was studied prospectively in pregnant women in France and their children by detection of anti-HCV with second-generation ELISA (ELISA2). In ELISA2-positive women, anti-HCV was detected with second- and third-generation RIBA (RIBA2 and RIBA3) and serum HCV RNA was detected with PCR. Among 670 women, anti-HIV1-negative, 26 (3.9%) were positive with ELISA2. RIBA2 was positive in 13 and HCV RNA was found in 10. Ten ELISA2-positive women had a further evaluation with assessment of HCV infection in their children. Among the 10 children born to the index pregnancy, only one was positive with ELISA2 and RIBA2 but negative with RIBA3 and PCR; the nine other children were ELISA2, RIBA2, RIBA3, and PCR negative. All 26 siblings (2-16 years old), of whom 14 were born to PCR-positive mothers, were ELISA2 and RIBA2 negative. We conclude that among anti-HIV1-negative pregnant women with normal serum ALT levels, the prevalence of HCV infection is relatively high but the risk for mother-to-infant transmission of HCV seems to be low.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8261814     DOI: 10.1007/bf01299888

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  Reactivity to c33c antigen as a marker of hepatitis C virus multiplication.

Authors:  M Martinot-Peignoux; P Marcellin; L Z Xu; J Bernuau; S Erlinger; J P Benhamou; D Larzul
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

2.  [Prevalence of hepatitis C virus antibodies (tests ELISA 2 and RIBA 2) in a population of pregnant women in France].

Authors:  F Roudot-Thoraval; L Deforges; P P Girollet; B Maria; J Milliez; D Pathier; J Duval; D Dhumeaux
Journal:  Gastroenterol Clin Biol       Date:  1992

3.  Second generation (RIBA) test in diagnosis of chronic hepatitis C.

Authors:  P Marcellin; M Martinot-Peignoux; N Boyer; M Pouteau; P Aumont; S Erlinger; J P Benhamou
Journal:  Lancet       Date:  1991-03-02       Impact factor: 79.321

4.  Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction.

Authors:  M Giovannini; A Tagger; M L Ribero; G Zuccotti; L Pogliani; A Grossi; P Ferroni; A Fiocchi
Journal:  Lancet       Date:  1990-05-12       Impact factor: 79.321

5.  Vertical transmission of hepatitis C virus.

Authors:  M M Thaler; C K Park; D V Landers; D W Wara; M Houghton; G Veereman-Wauters; R L Sweet; J H Han
Journal:  Lancet       Date:  1991-07-06       Impact factor: 79.321

6.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

Authors:  C L Van der Poel; H T Cuypers; H W Reesink; A J Weiner; S Quan; R Di Nello; J J Van Boven; I Winkel; D Mulder-Folkerts; P J Exel-Oehlers
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

7.  Mother-to-infant transmission of hepatitis C virus.

Authors:  R Wejstål; A Widell; A S Månsson; S Hermodsson; G Norkrans
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391

8.  Failure to detect vertical transmission of hepatitis C virus.

Authors:  J F Reinus; E L Leikin; H J Alter; L Cheung; M Shindo; B Jett; S Piazza; J W Shih
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391

9.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

10.  Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction.

Authors:  R Novati; V Thiers; A D Monforte; P Maisonneuve; N Principi; M Conti; A Lazzarin; C Brechot
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

View more
  8 in total

Review 1.  Chronic viral hepatitis.

Authors:  M H Chang
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

2.  The prevalence of HCV infection in a cohort of pregnant women, the related risk factors and the possibility of vertical transmission.

Authors:  M Tanzi; E Bellelli; G Benaglia; E Cavatorta; A Merialdi; E Mordacci; M L Ribero; A Tagger; C Verrotti; A Volpicelli
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

Review 3.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  Mother-to-infant transmission of hepatitis C virus: a prospective study.

Authors:  T Matsubara; R Sumazaki; H Takita
Journal:  Eur J Pediatr       Date:  1995-12       Impact factor: 3.183

5.  Vertical transmission of hepatitis C virus in low-risk pregnant women.

Authors:  C Pipan; S Amici; G Astori; G P Ceci; G A Botta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

6.  Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort.

Authors:  Steven A Pergam; Chia C Wang; Carolyn M Gardella; Taylor G Sandison; Warren T Phipps; Stephen E Hawes
Journal:  Am J Obstet Gynecol       Date:  2008-05-19       Impact factor: 8.661

7.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

Review 8.  The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis.

Authors:  Christina Greenaway; Ann Thu Ma; Lorie A Kloda; Marina Klein; Sonya Cnossen; Guido Schwarzer; Ian Shrier
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.